Establishes protocols for prescribing and dispensing benzodiazepine in New Jersey.
This bill establishes protocols for prescribing and dispensing benzodiazepine in New Jersey. It requires bold lettering labels on prescriptions to alert patients to the risk of dependence and addiction. The bill prohibits a single prescription from exceeding four weeks unless there is a proven medical need. The Department of Health is tasked with adopting rules to implement these protocols, including patient consent requirements and cautionary pamphlets for consumers. The provisions do not apply to pharmacists and practitioners in long-term care facilities.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.